Suppr超能文献

跨狭窄压力梯度预测肾血管性高血压患者肾动脉支架置入术后血压反应。

Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension.

机构信息

Cardiovascular Center, OLV-Clinic, Aalst, Belgium.

出版信息

Circ Cardiovasc Interv. 2010 Dec;3(6):537-42. doi: 10.1161/CIRCINTERVENTIONS.110.957704. Epub 2010 Nov 15.

Abstract

BACKGROUND

In previous studies on the effect of renal stenting on arterial hypertension, patients were selected mainly on the basis of angiographic parameters of the renal artery stenosis. The aim of the present study was to evaluate whether translesional pressure gradients could identify the patients with renal artery stenosis who might benefit from stenting.

METHODS AND RESULTS

A total of 53 consecutive hypertensive patients with unilateral RAS scheduled for renal artery intervention were recruited. Transstenotic pressure gradients were measured at baseline and during maximal hyperemia, before renal artery stenting. Twenty-four-hour ambulatory blood pressure measurements were performed in all patients before and 3 months after the intervention. Average reductions in systolic blood pressure and diastolic blood pressure at follow-up were -20±30 mm Hg and -2±12 mm Hg, respectively. At multivariate analysis, dopamine-induced mean gradient was the only independent predictor of the variations of both systolic blood pressure (regression coefficient=-4.03, standard error=1.11; P<0.001) and diastolic blood pressure (regression coefficient=-3.11, standard error=1.20; P=0.009). Patients who showed a decline in systolic blood pressure from the baseline value >20 mm Hg were considered as "responders." The optimal cutoff for identification of "responders" was a dopamine-induced mean gradient ≥20 mm Hg (area under the curve, 0.77; 95% confidence interval, 0.64 to 0.90; P=0.001).

CONCLUSIONS

A dopamine-induced mean pressure gradient of ≥20 mm Hg is highly predictive of arterial hypertension improvement after renal stenting, and therefore this measurement is useful for appropriate selection of patients with arterial hypertension.

摘要

背景

在先前关于肾动脉支架置入术对动脉高血压影响的研究中,主要根据肾动脉狭窄的血管造影参数选择患者。本研究旨在评估跨狭窄压力梯度是否可以识别可能受益于支架置入的肾动脉狭窄患者。

方法和结果

共纳入 53 例单侧肾动脉狭窄、计划进行肾动脉介入治疗的高血压患者。在肾动脉支架置入术前,于基础状态和最大充血时测量跨狭窄压力梯度。所有患者在干预前和干预后 3 个月均进行 24 小时动态血压监测。随访时收缩压和舒张压的平均降低值分别为-20±30mmHg 和-2±12mmHg。多变量分析显示,多巴胺诱导的平均梯度是收缩压(回归系数=-4.03,标准误差=1.11;P<0.001)和舒张压(回归系数=-3.11,标准误差=1.20;P=0.009)变化的唯一独立预测因素。收缩压从基线值下降>20mmHg 的患者被认为是“有反应者”。识别“有反应者”的最佳截断值为多巴胺诱导的平均梯度≥20mmHg(曲线下面积,0.77;95%置信区间,0.64 至 0.90;P=0.001)。

结论

多巴胺诱导的平均压力梯度≥20mmHg 高度预测肾动脉支架置入后动脉高血压的改善,因此该测量值有助于对动脉高血压患者进行适当选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验